3,507 Shares in Synopsys, Inc. $SNPS Bought by Cardinal Point Capital Management ULC

Cardinal Point Capital Management ULC bought a new stake in shares of Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 3,507 shares of the semiconductor company’s stock, valued at approximately $1,730,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Alpine Bank Wealth Management boosted its stake in Synopsys by 89.3% in the 3rd quarter. Alpine Bank Wealth Management now owns 53 shares of the semiconductor company’s stock worth $26,000 after purchasing an additional 25 shares in the last quarter. TFC Financial Management Inc. raised its holdings in shares of Synopsys by 1,250.0% in the third quarter. TFC Financial Management Inc. now owns 54 shares of the semiconductor company’s stock worth $27,000 after buying an additional 50 shares during the last quarter. Millstone Evans Group LLC acquired a new stake in shares of Synopsys during the third quarter worth $27,000. SOA Wealth Advisors LLC. acquired a new stake in shares of Synopsys during the third quarter worth $28,000. Finally, McIlrath & Eck LLC purchased a new stake in shares of Synopsys during the third quarter valued at $29,000. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

SNPS has been the subject of a number of research analyst reports. Weiss Ratings restated a “hold (c)” rating on shares of Synopsys in a research note on Thursday, January 22nd. Zacks Research upgraded Synopsys from a “strong sell” rating to a “hold” rating in a research note on Monday, November 10th. Citigroup initiated coverage on Synopsys in a report on Monday, November 24th. They set a “buy” rating and a $580.00 target price for the company. Morgan Stanley increased their price target on shares of Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Finally, KeyCorp raised their price target on shares of Synopsys from $575.00 to $600.00 and gave the stock an “overweight” rating in a research report on Thursday, December 11th. Nine research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $553.57.

Read Our Latest Report on SNPS

Insider Buying and Selling

In other news, insider Janet Lee sold 250 shares of Synopsys stock in a transaction on Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the completion of the sale, the insider directly owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the transaction, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 4,157 shares of company stock worth $1,945,036 over the last quarter. 0.62% of the stock is currently owned by insiders.

Synopsys Stock Up 4.0%

Synopsys stock opened at $426.88 on Monday. The stock has a market capitalization of $81.67 billion, a PE ratio of 53.43, a price-to-earnings-growth ratio of 3.56 and a beta of 1.12. The business has a 50 day simple moving average of $479.33 and a 200-day simple moving average of $495.06. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The business’s revenue was up 37.8% on a year-over-year basis. During the same period in the previous year, the company posted $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, analysts anticipate that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.